Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Liver Diseases

  Free Subscription

Articles published in Radiology

Retrieve available abstracts of 154 articles:
HTML format

Single Articles

    May 2020
  1. GIORGIO A, De Luca M, Gatti P, Matteucci P, et al
    CEUS LI-RADS Categories to Distinguish Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma Malignancies.
    Radiology. 2020 May 12:200623. doi: 10.1148/radiol.2020200623.

    April 2020
  2. ZHOU IY, Clavijo Jordan V, Rotile NJ, Akam E, et al
    Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Apr 28:192118. doi: 10.1148/radiol.2020192118.
    PubMed     Abstract available

    March 2020
  3. MULE S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, et al
    Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Radiology. 2020 Mar 31:192230. doi: 10.1148/radiol.2020192230.
    PubMed     Abstract available

  4. VERNUCCIO F, Ronot M, Dioguardi Burgio M, Cauchy F, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Mar 17:191790. doi: 10.1148/radiol.2020191790.
    PubMed     Abstract available

  5. LYSKE J, Hutchinson C, Manolea F, Patel VH, et al
    Case 275: Multiple Hepatic Hydatid Cysts.
    Radiology. 2020;294:716-719.
    PubMed     Abstract available

    February 2020
  6. KIM MJ
    Improving Survival with Gadoxetic Acid-enhanced MRI for Hepatocellular Carcinoma.
    Radiology. 2020 Feb 4:192713. doi: 10.1148/radiol.2020192713.

  7. HAN A, Zhang YN, Boehringer AS, Montes V, et al
    Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Radiology. 2020 Feb 4:191152. doi: 10.1148/radiol.2020191152.
    PubMed     Abstract available

  8. KANG TW, Kong SY, Kang D, Kang MW, et al
    Use of Gadoxetic Acid-enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis.
    Radiology. 2020 Feb 4:190639. doi: 10.1148/radiol.2020190639.
    PubMed     Abstract available

    January 2020
  9. JI GW, Zhu FP, Xu Q, Wang K, et al
    Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Radiology. 2020 Jan 14:191470. doi: 10.1148/radiol.2020191470.
    PubMed     Abstract available

    December 2019
  10. LIAO H, Ahmed M, Markezana A, Zeng G, et al
    Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model.
    Radiology. 2019 Dec 17:191023. doi: 10.1148/radiol.2019191023.
    PubMed     Abstract available

  11. CHAUDHRY M, McGinty KA, Mervak B, Lerebours R, et al
    The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.
    Radiology. 2019 Dec 17:191581. doi: 10.1148/radiol.2019191581.
    PubMed     Abstract available

    Toward Final Rescue of Contrast-enhanced US for the Diagnosis of Hepatocellular Carcinoma.
    Radiology. 2019 Dec 3:192309. doi: 10.1148/radiol.2019192309.

  13. YOON JH, Lee JM, Chang W, Kang HJ, et al
    Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
    Radiology. 2019 Dec 3:190794. doi: 10.1148/radiol.2019190794.
    PubMed     Abstract available

  14. HUANG JY, Li JW, Lu Q, Luo Y, et al
    Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Radiology. 2019 Dec 3:191086. doi: 10.1148/radiol.2019191086.
    PubMed     Abstract available

  15. KIM KW, Van den Abbeele AD
    Evolution of Transarterial Chemoembolization for the Treatment of Liver Cancer.
    Radiology. 2019;293:704-706.

  16. DURAN R, Namur J, Pascale F, Czuczman P, et al
    Vandetanib-eluting Radiopaque Beads: Pharmacokinetics, Safety, and Efficacy in a Rabbit Model of Liver Cancer.
    Radiology. 2019;293:695-703.
    PubMed     Abstract available

    November 2019
  17. SIDHU PS
    Using Contrast-enhanced US for Hepatocellular Carcinoma Assessment: Contrast-enhanced US LI-RADS version 2017 Classification Is Diagnostically Accurate.
    Radiology. 2019 Nov 26:192355. doi: 10.1148/radiol.2019192355.

  18. BASTATI N, Beer L, Mandorfer M, Poetter-Lang S, et al
    Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Radiology. 2019 Nov 19:190734. doi: 10.1148/radiol.2019190734.
    PubMed     Abstract available

    October 2019
    Complex Therapeutic Strategies for Hepatocellular Carcinoma: Expanding Criteria.
    Radiology. 2019 Oct 22:192151. doi: 10.1148/radiol.2019192151.

  20. SHI F, Wu M, Lian SS, Mo ZQ, et al
    Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes.
    Radiology. 2019 Oct 22:181991. doi: 10.1148/radiol.2019181991.
    PubMed     Abstract available

    Improving Postsurgical Outcome in Patients with HCC by Using a Hepatobiliary Contrast Agent.
    Radiology. 2019 Oct 8:191990. doi: 10.1148/radiol.2019191990.

  22. KIM DK, An C, Chung YE, Choi JY, et al
    Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
    Radiology. 2019 Oct 8:190414. doi: 10.1148/radiol.2019190414.
    PubMed     Abstract available

  23. MEYER M, Ronald J, Vernuccio F, Nelson RC, et al
    Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings.
    Radiology. 2019 Oct 1:190928. doi: 10.1148/radiol.2019190928.
    PubMed     Abstract available

  24. QUAIA E
    State of the Art: LI-RADS for Contrast-enhanced US.
    Radiology. 2019;293:4-14.
    PubMed     Abstract available

    September 2019
  25. GRAFFY PM, Sandfort V, Summers RM, Pickhardt PJ, et al
    Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment.
    Radiology. 2019 Sep 17:190512. doi: 10.1148/radiol.2019190512.
    PubMed     Abstract available

  26. LEE DH, Lee JY, Bae JS, Yi NJ, et al
    Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation.
    Radiology. 2019 Sep 10:190064. doi: 10.1148/radiol.2019190064.
    PubMed     Abstract available

  27. VIJ A, Fetzer DT
    Persistent Heterogeneous Liver Enhancement after US Contrast Material Injection.
    Radiology. 2019;292:539.

    August 2019
  28. GONSALVES CF, Eschelman DJ, Adamo RD, Anne PR, et al
    A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
    Radiology. 2019 Aug 27:190199. doi: 10.1148/radiol.2019190199.
    PubMed     Abstract available

  29. ALVES PEREIRA FD, Hickson ML, Wilson PAJ
    Case 268: Bilateral Adrenal Hemorrhage in the Context of Sepsis.
    Radiology. 2019;292:503-506.
    PubMed     Abstract available

    July 2019
  30. JONDAL DE, Thompson SM, Butters KA, Knudsen BE, et al
    Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in Small-Animal Model.
    Radiology. 2019 Jul 23:190115. doi: 10.1148/radiol.2019190115.
    PubMed     Abstract available

  31. WHITE SB
    Treatment of Hepatocellular Carcinoma:Time for a Paradigm Shift?
    Radiology. 2019 Jul 23:191474. doi: 10.1148/radiol.2019191474.

  32. LEE SM, Lee JM, Ahn SJ, Kang HJ, et al
    LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
    Radiology. 2019 Jul 16:182867. doi: 10.1148/radiol.2019182867.
    PubMed     Abstract available

  33. PARK JH, Park MS, Lee SJ, Jeong WK, et al
    Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Radiology. 2019 Jul 9:190183. doi: 10.1148/radiol.2019190183.
    PubMed     Abstract available

  34. KIM DH, Choi SH, Kim SY, Kim MJ, et al
    Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
    Radiology. 2019;292:270.

    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
    Radiology. 2019;292:235-236.

  36. SHROPSHIRE EL, Chaudhry M, Miller CM, Allen BC, et al
    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
    Radiology. 2019;292:226-234.
    PubMed     Abstract available

    June 2019
  37. MILOT L
    Does Hepatocellular Carcinoma Screening with US Work? Using the US LI-RADS Algorithm.
    Radiology. 2019 Jun 18:191105. doi: 10.1148/radiol.2019191105.

  38. SON JH, Choi SH, Kim SY, Jang HY, et al
    Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Radiology. 2019 Jun 18:190035. doi: 10.1148/radiol.2019190035.
    PubMed     Abstract available

  39. PADIA SA
    Is Idarubicin the Future of TACE?
    Radiology. 2019;291:809-810.

  40. FOWLER KJ, Sirlin CB
    Is It Time to Expand the Definition of Washout Appearance in LI-RADS?
    Radiology. 2019;291:658-659.

    May 2019
    Combination Therapy in Intermediate-Stage Hepatocellular Carcinoma: Do We Need to Know about Microvascular Invasion?
    Radiology. 2019 May 28:190921. doi: 10.1148/radiol.2019190921.

  42. PENG Z, Chen S, Xiao H, Wang Y, et al
    Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Radiology. 2019 May 28:181818. doi: 10.1148/radiol.2019181818.
    PubMed     Abstract available

    Probing the Liver-Heart Axis.
    Radiology. 2019;291:338-339.

    April 2019
  44. GUIU B, Chevallier P, Assenat E, Barbier E, et al
    Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial.
    Radiology. 2019 Apr 30:182399. doi: 10.1148/radiol.2019182399.
    PubMed     Abstract available

  45. KIM DH, Choi SH, Kim SY, Kim MJ, et al
    Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
    Radiology. 2019 Apr 16:182587. doi: 10.1148/radiol.2019182587.
    PubMed     Abstract available

  46. FURLAN A
    New Progress toward Validation of LI-RADS Version 2018.
    Radiology. 2019;291:81-82.

    March 2019
  47. VITA T, Murphy DJ, Osborne MT, Bajaj NS, et al
    Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.
    Radiology. 2019 Mar 5:181793. doi: 10.1148/radiol.2019181793.
    PubMed     Abstract available

  48. LUCATELLI P, De Rubeis G, Rocco B, Bezzi M, et al
    Are Radiopaque Beads a Real Advantage?
    Radiology. 2019;290:852-853.

    January 2019
  49. KIM YY, Kim MJ, Kim EH, Roh YH, et al
    Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018.
    Radiology. 2019 Jan 29:181995. doi: 10.1148/radiol.2019181995.
    PubMed     Abstract available

  50. HEERINK WJ, Ruiter SJS, Pennings JP, Lansdorp B, et al
    Robotic versus Freehand Needle Positioning in CT-guided Ablation of Liver Tumors: A Randomized Controlled Trial.
    Radiology. 2019 Jan 22:181698. doi: 10.1148/radiol.2018181698.
    PubMed     Abstract available

  51. GRAY MD, Lyon PC, Mannaris C, Folkes LK, et al
    Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.
    Radiology. 2019 Jan 15:181445. doi: 10.1148/radiol.2018181445.
    PubMed     Abstract available

  52. YOON JH, Lee JM
    Can MRI Features Predict Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma?
    Radiology. 2019 Jan 8:182775. doi: 10.1148/radiol.2018182775.

  53. MIN JH, Kim YK, Choi SY, Kang TW, et al
    Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
    Radiology. 2019 Jan 8:181485. doi: 10.1148/radiol.2018181485.
    PubMed     Abstract available

    December 2018
  54. POOLER BD, Wiens CN, McMillan A, Artz NS, et al
    Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study.
    Radiology. 2018 Dec 18:181134. doi: 10.1148/radiol.2018181134.
    PubMed     Abstract available

  55. WESTON AD, Korfiatis P, Kline TL, Philbrick KA, et al
    Automated Abdominal Segmentation of CT Scans for Body Composition Analysis Using Deep Learning.
    Radiology. 2018 Dec 11:181432. doi: 10.1148/radiol.2018181432.
    PubMed     Abstract available

  56. CURTIS WA, Fraum TJ, An H, Chen Y, et al
    Quantitative MRI of Diffuse Liver Disease: Current Applications and Future Directions.
    Radiology. 2018 Dec 4:172765. doi: 10.1148/radiol.2018172765.
    PubMed     Abstract available

  57. PARK HJ, Lee SS, Park B, Yun J, et al
    Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis.
    Radiology. 2018 Dec 4:181197. doi: 10.1148/radiol.2018181197.
    PubMed     Abstract available

    November 2018
  58. JENSEN CT, Wagner-Bartak NA, Vu LN, Liu X, et al
    Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT.
    Radiology. 2018 Nov 27:181657. doi: 10.1148/radiol.2018181657.
    PubMed     Abstract available

  59. QI X, An W, Liu F, Qi R, et al
    Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.
    Radiology. 2018 Nov 20:180425. doi: 10.1148/radiol.2018180425.
    PubMed     Abstract available

    Virtual Hepatic Venous Pressure Gradient with CT: Ready for Prime Time?
    Radiology. 2018 Nov 20:182351. doi: 10.1148/radiol.2018182351.

  61. BASHIR MR, Chernyak V
    Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings?
    Radiology. 2018 Nov 13:182408. doi: 10.1148/radiol.2018182408.

  62. CHOI SH, Lee SS, Park SH, Kim KM, et al
    LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.
    Radiology. 2018 Nov 13:181290. doi: 10.1148/radiol.2018181290.
    PubMed     Abstract available

    October 2018
  63. YOON JH, Lee JM, Kang HJ, Ahn SJ, et al
    Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.
    Radiology. 2018 Oct 30:180753. doi: 10.1148/radiol.2018180753.
    PubMed     Abstract available

  64. MOTOSUGI U, Roldan-Alzate A, Bannas P, Said A, et al
    Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis.
    Radiology. 2018 Oct 16:180230. doi: 10.1148/radiol.2018180230.
    PubMed     Abstract available

  65. KHALAF MH, Sundaram V, AbdelRazek Mohammed MA, Shah R, et al
    A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
    Radiology. 2018 Oct 9:180257. doi: 10.1148/radiol.2018180257.
    PubMed     Abstract available

    September 2018
  66. CHERNYAK V, Fowler KJ, Kamaya A, Kielar AZ, et al
    Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
    Radiology. 2018 Sep 25:181494. doi: 10.1148/radiol.2018181494.
    PubMed     Abstract available

  67. FLETCHER JG, Fidler JL, Venkatesh S, Hough DM, et al
    Observer Performance with Varying Radiation Dose and Reconstruction Methods for Detection of Hepatic Metastases.
    Radiology. 2018 Sep 11:180125. doi: 10.1148/radiol.2018180125.
    PubMed     Abstract available

  68. SARTORIS R, Rautou PE, Elkrief L, Pollorsi G, et al
    Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
    Radiology. 2018 Sep 4:181131. doi: 10.1148/radiol.2018181131.
    PubMed     Abstract available

  69. BASTIAANNET R, van Roekel C, Kunnen B, Lam MGEH, et al
    Is Diffusion-weighted MRI Really Superior to PET/CT in Predicting Survival after Radioembolization?
    Radiology. 2018 Sep 4:181348. doi: 10.1148/radiol.2018181348.

  70. SMITH AD
    Enter the Era of Quantitative Liver CT.
    Radiology. 2018 Sep 4:181847. doi: 10.1148/radiol.2018181847.

  71. CHOI KJ, Jang JK, Lee SS, Sung YS, et al
    Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver.
    Radiology. 2018 Sep 4:180763. doi: 10.1148/radiol.2018180763.
    PubMed     Abstract available

    August 2018
  72. PANDEY A, Pandey P, Ghasabeh MA, Zarghampour M, et al
    Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
    Radiology. 2018 Aug 21:180450. doi: 10.1148/radiol.2018180450.
    PubMed     Abstract available

  73. CHUNG JW, Kim HC
    Can CT Following Chemoembolization with Radiopaque Drug-Eluting Beads Tell Us How Much Drug We Deliver?
    Radiology. 2018 Aug 14:181275. doi: 10.1148/radiol.2018181275.

  74. MIKHAIL AS, Pritchard WF, Negussie AH, Krishnasamy VP, et al
    Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.
    Radiology. 2018 Aug 14:172571. doi: 10.1148/radiol.2018172571.
    PubMed     Abstract available

    July 2018
  75. BARR RG
    Liver Elastography Still in Its Infancy.
    Radiology. 2018;288:107-108.

  76. HUDERT CA, Tzschatzsch H, Guo J, Rudolph B, et al
    US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Radiology. 2018;288:99-106.
    PubMed     Abstract available

    June 2018
  77. LUETKENS JA, Klein S, Traber F, Schmeel FC, et al
    Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results.
    Radiology. 2018 Jun 26:180051. doi: 10.1148/radiol.2018180051.
    PubMed     Abstract available

  78. JOHNSON PT, Fishman EK
    Hereditary Hemorrhagic Telangiectasia: Cinematic Rendering of Hepatic Arteriovenous Malformations.
    Radiology. 2018 Jun 19:180380. doi: 10.1148/radiol.2018180380.

  79. HEVERHAGEN JT, Kudrnova S
    Subcentimeter Hepatocellular Carcinoma: A New Paradigm for Treatment with Percutaneous Radiofrequency Ablation?
    Radiology. 2018 Jun 19:180977. doi: 10.1148/radiol.2018180977.

  80. SONG KD, Lee MW, Rhim H, Kang TW, et al
    Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Radiology. 2018 Jun 19. doi: 10.1148/radiol.2018172743.
    PubMed     Abstract available

  81. BREHMER K, Brismar TB, Morsbach F, Svensson A, et al
    Triple Arterial Phase CT of the Liver with Radiation Dose Equivalent to That of Single Arterial Phase CT: Initial Experience.
    Radiology. 2018 Jun 19:172875. doi: 10.1148/radiol.2018172875.
    PubMed     Abstract available

  82. JOO I, Lee JM, Yoon JH
    Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
    Radiology. 2018 Jun 5:171187. doi: 10.1148/radiol.2018171187.
    PubMed     Abstract available

  83. FANG C, Jaffer OS, Yusuf GT, Konstantatou E, et al
    Reducing the Number of Measurements in Liver Point Shear-Wave Elastography: Factors that Influence the Number and Reliability of Measurements in Assessment of Liver Fibrosis in Clinical Practice.
    Radiology. 2018;287:844-852.
    PubMed     Abstract available

  84. TROUT AT, Sheridan RM, Serai SD, Xanthakos SA, et al
    Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases.
    Radiology. 2018;287:824-832.
    PubMed     Abstract available

    May 2018
  85. BARABASCH A, Heinzel A, Bruners P, Kraemer NA, et al
    Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing (90)Y Radioembolization of Hepatic Metastases.
    Radiology. 2018 May 21:170408. doi: 10.1148/radiol.2018170408.
    PubMed     Abstract available

  86. DEVULAPALLI KK, Fidelman N, Soulen MC, Miller M, et al
    (90)Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.
    Radiology. 2018 May 8:170962. doi: 10.1148/radiol.2018170962.
    PubMed     Abstract available

  87. JONDAL DE, Thompson SM, Butters KA, Knudsen BE, et al
    Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT Signaling.
    Radiology. 2018 May 8:172944. doi: 10.1148/radiol.2018172944.
    PubMed     Abstract available

    Radiofrequency Ablation versus Resection for Small Hepatocellular Carcinoma: Are Randomized Controlled Trials Still Needed?
    Radiology. 2018;287:473-475.

  89. POMPER MG, Lee S
    Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential.
    Radiology. 2018;287:590-591.

    April 2018
    Radiation Segmentectomy for Hepatocellular Carcinoma: Ready for Prime Time?
    Radiology. 2018 Apr 24:180163. doi: 10.1148/radiol.2018180163.

  91. LEWANDOWSKI RJ, Gabr A, Abouchaleh N, Ali R, et al
    Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma.
    Radiology. 2018 Apr 24:171768. doi: 10.1148/radiol.2018171768.
    PubMed     Abstract available

  92. ZHU K, Huang J, Lai L, Huang W, et al
    Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Apr 24:172028. doi: 10.1148/radiol.2018172028.
    PubMed     Abstract available

  93. CERNY M, Bergeron C, Billiard JS, Murphy-Lavallee J, et al
    LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features.
    Radiology. 2018 Apr 10:171678. doi: 10.1148/radiol.2018171678.
    PubMed     Abstract available

  94. SHYN PB, Casadaban LC, Sainani NI, Sadow CA, et al
    Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Radiology. 2018 Apr 3:172108. doi: 10.1148/radiol.2018172108.
    PubMed     Abstract available

  95. WANG X, Su Z, Lyu T, Figini M, et al
    (18)F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.
    Radiology. 2018;287:137-145.
    PubMed     Abstract available

    March 2018
  96. MULE S, Thiefin G, Costentin C, Durot C, et al
    Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.
    Radiology. 2018 Mar 27:171320. doi: 10.1148/radiol.2018171320.
    PubMed     Abstract available

  97. PANDEY A, Pandey P, Aliyari Ghasabeh M, Najmi Varzaneh F, et al
    Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
    Radiology. 2018 Mar 27:171593. doi: 10.1148/radiol.2018171593.
    PubMed     Abstract available

  98. TA CN, Kono Y, Eghtedari M, Oh YT, et al
    Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings.
    Radiology. 2018;286:1062-1071.
    PubMed     Abstract available

    February 2018
  99. CHOI SH, Byun JH, Lim YS, Lee SJ, et al
    Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules.
    Radiology. 2018 Feb 19:170748. doi: 10.1148/radiol.2018170748.
    PubMed     Abstract available

  100. PENG Z, Chen S, Wei M, Lin M, et al
    Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Feb 1:171541. doi: 10.1148/radiol.2018171541.
    PubMed     Abstract available

  101. MURALI N, Laage-Gaupp FM, Chapiro J, Geschwind JF, et al
    Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects-Is Network Pathway Analysis the Final Piece of the Puzzle?
    Radiology. 2018;286:405-408.
    PubMed     Abstract available

  102. BOESCH C
    Quantitative MR Imaging Is Increasingly Important in Liver Disease.
    Radiology. 2018;286:557-559.

    January 2018
  103. KWEE SA, Wong L, Chan OTM, Kalathil S, et al
    PET/CT with (18)F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.
    Radiology. 2018 Jan 9:171333. doi: 10.1148/radiol.2018171333.
    PubMed     Abstract available

  104. LEE DH, Lee JM, Kang TW, Rhim H, et al
    Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study.
    Radiology. 2018;286:338-349.
    PubMed     Abstract available

    December 2017
  105. YU SCH, Chan SL, Lee KF, Hui JWY, et al
    Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.
    Radiology. 2017 Dec 22:170154. doi: 10.1148/radiol.2017170154.
    PubMed     Abstract available

  106. YASAKA K, Akai H, Kunimatsu A, Abe O, et al
    Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Radiology. 2017 Dec 14:171928. doi: 10.1148/radiol.2017171928.
    PubMed     Abstract available

  107. SANDOW TA, Arndt SE, Albar AA, DeVun DA, et al
    Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort.
    Radiology. 2017 Dec 4:170731. doi: 10.1148/radiol.2017170731.
    PubMed     Abstract available

  108. SHAMIR SB, Kurian J, Kogan-Liberman D, Taragin BH, et al
    Hepatic Imaging in Neonates and Young Infants: State of the Art.
    Radiology. 2017;285:763-777.
    PubMed     Abstract available

  109. YANG X
    Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles.
    Radiology. 2017;285:699-701.
    PubMed     Abstract available

  110. WHITE SB, Kim DH, Guo Y, Li W, et al
    Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases.
    Radiology. 2017;285:809-819.
    PubMed     Abstract available

    November 2017
  111. CHOI SY, Kim SH, Park CK, Min JH, et al
    Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Radiology. 2017 Nov 21:162846. doi: 10.1148/radiol.2017162846.
    PubMed     Abstract available

  112. TANG A, Bashir MR, Corwin MT, Cruite I, et al
    Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
    Radiology. 2017 Nov 21:170554. doi: 10.1148/radiol.2017170554.
    PubMed     Abstract available

  113. FARRAR CT, Gale EM, Kennan R, Ramsay I, et al
    CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis.
    Radiology. 2017 Nov 20:170595. doi: 10.1148/radiol.2017170595.
    PubMed     Abstract available

  114. XU XL, Liu XD, Liang M, Luo BM, et al
    Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis.
    Radiology. 2017 Nov 13:162756. doi: 10.1148/radiol.2017162756.
    PubMed     Abstract available

  115. SEROR O, Nault JC, N'Kontchou G, Sutter O, et al
    Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental 90Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?
    Radiology. 2017;285:690-691.

  116. ADAM LC, Murali N, Chapiro J, Geschwind JF, et al
    Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?
    Radiology. 2017;285:333-335.
    PubMed     Abstract available

  117. YAN F, Wang S, Yang W, Goldberg SN, et al
    Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
    Radiology. 2017;285:462-471.
    PubMed     Abstract available

  118. FOWLER KJ, Tang A, Santillan C, Bhargavan-Chatfield M, et al
    Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
    Radiology. 2017 Nov 1:170376. doi: 10.1148/radiol.2017170376.
    PubMed     Abstract available

    October 2017
  119. YASAKA K, Akai H, Abe O, Kiryu S, et al
    Deep Learning with Convolutional Neural Network for Differentiation of Liver Masses at Dynamic Contrast-enhanced CT: A Preliminary Study.
    Radiology. 2017 Oct 27:170706. doi: 10.1148/radiol.2017170706.
    PubMed     Abstract available

    September 2017
  120. WANG WT, Yang L, Yang ZX, Hu XX, et al
    Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging.
    Radiology. 2017 Sep 22:170515. doi: 10.1148/radiol.2017170515.
    PubMed     Abstract available

  121. RUNGE JH, Smits LP, Verheij J, Depla A, et al
    MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Radiology. 2017 Sep 15:162931. doi: 10.1148/radiol.2017162931.
    PubMed     Abstract available

  122. YOKOO T, Serai SD, Pirasteh A, Bashir MR, et al
    Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.
    Radiology. 2017 Sep 11:170550. doi: 10.1148/radiol.2017170550.
    PubMed     Abstract available

  123. KUMAR G, Goldberg SN, Gourevitch S, Levchenko T, et al
    Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.
    Radiology. 2017 Sep 6:162943. doi: 10.1148/radiol.2017162943.
    PubMed     Abstract available

    August 2017
  124. FRAUM TJ, Tsai R, Rohe E, Ludwig DR, et al
    Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014.
    Radiology. 2017 Aug 29:170114. doi: 10.1148/radiol.2017170114.
    PubMed     Abstract available

  125. DISTELMAIER M, Barabasch A, Heil P, Kraemer NA, et al
    Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Radiology. 2017 Aug 11:161561. doi: 10.1148/radiol.2017161561.
    PubMed     Abstract available

  126. RONALD J, Nixon AB, Marin D, Gupta RT, et al
    Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
    Radiology. 2017 Aug 8:162555. doi: 10.1148/radiol.2017162555.
    PubMed     Abstract available

  127. WAGNER M, Corcuera-Solano I, Lo G, Esses S, et al
    Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study.
    Radiology. 2017;284:401-412.
    PubMed     Abstract available

    July 2017
  128. LV Y, He C, Wang Z, Guo W, et al
    Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.
    Radiology. 2017 Jul 5:162266. doi: 10.1148/radiol.2017162266.
    PubMed     Abstract available

  129. LEE JM
    Old and New MR Tools to Measure Hepatic Steatosis: Is Their Diagnostic Accuracy the Same?
    Radiology. 2017;284:303-304.

  130. HARZ C, Schockel L, Endrikat J, Pietsch H, et al
    Signal Intensity Increase in the Central Nervous System after Previous Gadoxetic Acid-enhanced MR Imaging.
    Radiology. 2017;284:299-301.

    June 2017
  131. KIM BR, Lee JM, Lee DH, Yoon JH, et al
    Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.
    Radiology. 2017 Jun 13:162080. doi: 10.1148/radiol.2017162080.
    PubMed     Abstract available

  132. LEE DH, Lee JY, Lee KB, Han JK, et al
    Evaluation of Hepatic Steatosis by Using Acoustic Structure Quantification US in a Rat Model: Comparison with Pathologic Examination and MR Spectroscopy.
    Radiology. 2017 Jun 13:161923. doi: 10.1148/radiol.2017161923.
    PubMed     Abstract available

  133. GOSHIMA S, Bae KT
    Liver Surface Nodularity as a Biomarker for Detection and Evaluation of Cirrhosis.
    Radiology. 2017;283:921-922.

  134. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Radiology. 2017;283:923.

  135. SAVIC LJ, Chapiro J, Geschwind JF
    Science to Practice: Killing Dormant Cells-Is Targeting Autophagy the Key to Complete Tumor Response in Transarterial Chemoembolization?
    Radiology. 2017;283:621-623.
    PubMed     Abstract available

  136. GARCOVICH M, Veraldi S, Di Stasio E, Zocco MA, et al
    Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography.
    Radiology. 2017;283:820-827.
    PubMed     Abstract available

    May 2017
  137. KAO WY, Su CW, Chiou YY, Chiu NC, et al
    Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.
    Radiology. 2017 May 30:162382. doi: 10.1148/radiol.2017162382.
    PubMed     Abstract available

  138. WIDYA RL, de Mutsert R, Westenberg JJM, Gast KB, et al
    Is Hepatic Triglyceride Content Associated with Aortic Pulse Wave Velocity and Carotid Intima-Media Thickness? The Netherlands Epidemiology of Obesity Study.
    Radiology. 2017 May 29:160916. doi: 10.1148/radiol.2017160916.
    PubMed     Abstract available

  139. LEE KS, Santagostino SF, Li D, Ramjit A, et al
    Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis.
    Radiology. 2017 May 11:162617. doi: 10.1148/radiol.2017162617.
    PubMed     Abstract available

  140. KUHN JP, Meffert P, Heske C, Kromrey ML, et al
    Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Radiology. 2017 May 5. doi: 10.1148/radiol.2017161228.
    PubMed     Abstract available

    April 2017
  141. SUTTER O, Calvo J, N'Kontchou G, Nault JC, et al
    Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Radiology. 2017 Apr 28:161413. doi: 10.1148/radiol.2017161413.
    PubMed     Abstract available

  142. CHEN R, Li J, Zhou X, Liu J, et al
    Fructose-1,6-Bisphosphatase 1 Reduces 18F FDG Uptake in Hepatocellular Carcinoma.
    Radiology. 2017 Apr 6:161607. doi: 10.1148/radiol.2017161607.
    PubMed     Abstract available

  143. ETCHELL E, Juge L, Hatt A, Sinkus R, et al
    Liver Stiffness Values Are Lower in Pediatric Subjects than in Adults and Increase with Age: A Multifrequency MR Elastography Study.
    Radiology. 2017;283:222-230.
    PubMed     Abstract available

    March 2017
  144. PULLI B, Wojtkiewicz G, Iwamoto Y, Ali M, et al
    Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
    Radiology. 2017 Mar 30:160588. doi: 10.1148/radiol.2017160588.
    PubMed     Abstract available

  145. PARK MJ, Hong N, Han K, Kim MJ, et al
    Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Radiology. 2017 Mar 22:161619. doi: 10.1148/radiol.2017161619.
    PubMed     Abstract available

    February 2017
  146. HYODO T, Yada N, Hori M, Maenishi O, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation.
    Radiology. 2017 Feb 17:160130. doi: 10.1148/radiol.2017160130.
    PubMed     Abstract available

  147. SOLOMON J, Marin D, Roy Choudhury K, Patel B, et al
    Effect of Radiation Dose Reduction and Reconstruction Algorithm on Image Noise, Contrast, Resolution, and Detectability of Subtle Hypoattenuating Liver Lesions at Multidetector CT: Filtered Back Projection versus a Commercial Model-based Iterative Rec
    Radiology. 2017 Feb 7:161736. doi: 10.1148/radiol.2017161736.
    PubMed     Abstract available

  148. MICHEL LS, Dyroff S, Brooks FJ, Spayd KJ, et al
    PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
    Radiology. 2017;282:453-463.
    PubMed     Abstract available

    December 2016
  149. KIM YK, Lin WC, Sung K, Raman SS, et al
    Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate.
    Radiology. 2016 Dec 15:160241.
    PubMed     Abstract available

  150. BELLINI D, Ramirez-Giraldo JC, Bibbey A, Solomon J, et al
    Dual-Source Single-Energy Multidetector CT Used to Obtain Multiple Radiation Exposure Levels within the Same Patient: Phantom Development and Clinical Validation.
    Radiology. 2016 Dec 5:161233.
    PubMed     Abstract available

    November 2016
  151. SAHU S, Schernthaner R, Ardon R, Chapiro J, et al
    Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
    Radiology. 2016 Nov 10:160838.
    PubMed     Abstract available

    October 2016
  152. SERAI SD, Dillman JR, Trout AT
    Spin-echo Echo-planar Imaging MR Elastography versus Gradient-echo MR Elastography for Assessment of Liver Stiffness in Children and Young Adults Suspected of Having Liver Disease.
    Radiology. 2016 Oct 10:160589.
    PubMed     Abstract available

    August 2016
  153. HYODO T, Hori M, Lamb P, Sasaki K, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation.
    Radiology. 2016 Aug 19:160129.
    PubMed     Abstract available

    June 2016
  154. TROUT AT, Serai S, Mahley AD, Wang H, et al
    Liver Stiffness Measurements with MR Elastography: Agreement and Repeatability across Imaging Systems, Field Strengths, and Pulse Sequences.
    Radiology. 2016 Jun 10:160209.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.